Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 / ...

A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

The Stratus COVID-19 variant, which includes the XFG and XFG.3 strains, currently accounts for around 30 per cent of COVID-19 ...

Even four years after the start of the COVID-19 pandemic, California residents aren't living as long as they used to.

The full approval of Spikevax covers children aged six months through 11 years who are at increased risk for severe COVID-19, transitioning the vaccine from emergency use to full licensure.

Public hearings for the second phase of the Royal Commission of Inquiry into Covid-19 Lessons Learned began in Auckland this ...

A Ponte Vedra Beach man pleaded guilty to several charges in connection with a fraud scheme involving COVID-19 personal ...

Medical associations representing hundreds of thousands of doctors, medical professionals and scientists in the United States ...

South Africa’s health ministry has expressed concern about a persistent campaign of Covid-19 vaccine disinformation ...

A conservative podcast group organized an event in support of Dr. Kirk Moore, accused in federal court of discarding COVID-19 ...

The suspect was detained in Milan on charges that he's a member of a Chinese state-sponsored hacking group called Silk ...

Italian authorities have arrested a Chinese man accused by US prosecutors of being part of a hacking team that stole coveted ...